USPH — U.S. Physical Therapy Inc. stock price and chart

USPH

$87.02+3.71%

as of close, Oct 20, 2026

☾ AH $87.02 +3.71%

U.S. Physical Therapy Inc.Stock · HealthcareRussell 2000 · 0.03% of IWMUS Stock Market · 0.001% of VTIRussell 3000 · 0.001% of IWV

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEEEEEEEEEE

20162019202120242026

60.070.080.090.0100.0110.0120.0130.0140.002.0M$87.02

2026-10-20

Price$87.02

MA20$74.66

MA50$78.24

Vol857.8K

What would $1,000 invested in USPH be worth today? →

USPH returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $87.02
YTD price return: +11.44%
YTD total return: +13.59%
Next earnings: Nov 4, 2026
Market cap: 1.3B2016-12 879M2026-10 1.3B+47.7% over the window
Enterprise value: 1.7B
Shares outstanding: 14.9M2016-06 12.5M2026-06 14.9M+19.2% over the window
52W low: $58.19
52W high: $93.50
From 52W high: -6.93%
From 52W low: +49.54%
52W range: 82%

Volume

Rel volume: 0.96×
30D volume: 184.6K
30D $ vol: 15.4M

Fundamentals

Sales (ttm): 812.2M2016-06 348.1M2026-06 812.2M+133.3% over the window
Sales/share: $54.432016-06 $27.802026-06 $54.43+95.8% over the window
EPS (ttm): $2.132016-06 $1.952026-06 $2.13+9.1% over the window
FCF (ttm): 64.1M2016-06 44.5M2026-06 64.1M+44.0% over the window
FCF/share: $4.292016-06 $3.552026-06 $4.29+20.8% over the window
Book value/share: $30.072016-06 $14.402026-06 $30.07+108.8% over the window
Net margin: 3.97%2016-06 6.0%2026-06 4.0%-33.5% over the window
ROE: 7.18%2016-06 11.5%2026-06 7.2%-37.6% over the window
ROA: 2.58%2016-06 6.1%2026-06 2.6%-58.0% over the window
Debt / equity: 0.48×2016-06 0.262026-06 0.48+84.0% over the window
Current ratio: 1.272016-06 2.452026-06 1.27-48.1% over the window

Growth (CAGR, ttm) · 10Y

Sales: +11.33%2025-06-30 → 2026-06-30729.6M → 812.2M (+11.3% total)+11.83%2023-06-30 → 2026-06-30580.8M → 812.2M (+39.8% total)+11.77%2021-06-30 → 2026-06-30465.7M → 812.2M (+74.4% total)+8.84%2016-06-30 → 2026-06-30348.1M → 812.2M (+133.3% total)
Net income: -15.57%2025-06-30 → 2026-06-3038.2M → 32.2M (-15.6% total)+1.86%2023-06-30 → 2026-06-3030.5M → 32.2M (+5.7% total)-6.27%2021-06-30 → 2026-06-3044.6M → 32.2M (-27.7% total)+4.49%2016-06-30 → 2026-06-3020.8M → 32.2M (+55.2% total)
FCF: +5.26%2025-06-30 → 2026-06-3060.9M → 64.1M (+5.3% total)+1.32%2023-06-30 → 2026-06-3061.6M → 64.1M (+4.0% total)-4.55%2021-06-30 → 2026-06-3080.9M → 64.1M (-20.8% total)+3.71%2016-06-30 → 2026-06-3044.5M → 64.1M (+44.0% total)
Shares: -1.85%2025-06-30 → 2026-06-3015.2M → 14.9M (-1.9% total)+2.84%2023-06-30 → 2026-06-3013.7M → 14.9M (+8.8% total)+2.95%2021-06-30 → 2026-06-3012.9M → 14.9M (+15.6% total)+1.77%2016-06-30 → 2026-06-3012.5M → 14.9M (+19.2% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -15.72%2025-06-30 → 2026-06-30$2.52 → $2.13 (-15.7% total)-2.75%2023-06-30 → 2026-06-30$2.31 → $2.13 (-8.0% total)-9.29%2021-06-30 → 2026-06-30$3.46 → $2.13 (-38.6% total)+0.87%2016-06-30 → 2026-06-30$1.95 → $2.13 (+9.1% total)
Sales/share: +13.43%2025-06-30 → 2026-06-30$47.99 → $54.43 (+13.4% total)+8.74%2023-06-30 → 2026-06-30$42.33 → $54.43 (+28.6% total)+8.57%2021-06-30 → 2026-06-30$36.08 → $54.43 (+50.8% total)+6.95%2016-06-30 → 2026-06-30$27.80 → $54.43 (+95.8% total)
FCF/share: +7.25%2025-06-30 → 2026-06-30$4.00 → $4.29 (+7.2% total)-1.48%2023-06-30 → 2026-06-30$4.49 → $4.29 (-4.4% total)-7.28%2021-06-30 → 2026-06-30$6.27 → $4.29 (-31.5% total)+1.91%2016-06-30 → 2026-06-30$3.55 → $4.29 (+20.8% total)
Book value/share: -8.72%2025-06-30 → 2026-06-30$32.94 → $30.07 (-8.7% total)-5.48%2023-06-30 → 2026-06-30$35.60 → $30.07 (-15.6% total)+6.45%2021-06-30 → 2026-06-30$21.99 → $30.07 (+36.7% total)+7.64%2016-06-30 → 2026-06-30$14.40 → $30.07 (+108.8% total)
Dividend/share: +2.25%2025-06-30 → 2026-06-30$1.78 → $1.82 (+2.2% total)+2.70%2023-06-30 → 2026-06-30$1.68 → $1.82 (+8.3% total)+1.86%2021-06-30 → 2026-06-30$1.66 → $1.82 (+9.6% total)+11.02%2016-06-30 → 2026-06-30$0.64 → $1.82 (+184.4% total)
Price: -2.90%2025-10-20 → 2026-10-20$89.62 → $87.02 (-2.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.20%2023-10-20 → 2026-10-20$87.54 → $87.02 (-0.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-4.12%2021-10-20 → 2026-10-20$107.39 → $87.02 (-19.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+3.28%2016-10-19 → 2026-10-20$63.04 → $87.02 (+38.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -0.40%2025-10-20 → 2026-10-20$87.37 → $87.02 (-0.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+2.03%2023-10-20 → 2026-10-20$81.93 → $87.02 (+6.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-2.17%2021-10-20 → 2026-10-20$97.13 → $87.02 (-10.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.81%2016-10-19 → 2026-10-20$54.39 → $87.02 (+60.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 40.9×2016-12 43.812026-10 40.29-8.0% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 17.0×2016-12 17.172026-10 16.97-1.2% over the window
Fwd P/E: 25.0×
P/S (ttm)Market cap ÷ TTM revenue.: 1.6×2016-12 2.492026-10 1.60-35.9% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.9×2016-12 4.772026-10 2.89-39.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 20.3×2016-12 20.372026-10 20.27-0.5% over the window
EV/EBITDA (fy): 16.8×
EV/Sales (ttm): 2.0×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.93%2016-09 4.9%2026-06 6.3%+27.3% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 2.11%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 2.10%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $1.84
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 14.9M ÷ 15.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 1.85%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.85%) + dividends paid over that year ($27.6M) ÷ market_cap_at(2025-06-30) ($1.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 4.17%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($24.8M) ÷ today's market cap ($1.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 1.91%2016-09 0.0%2026-06 2.4%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $24.8M + TTM dividends $27.6M) ÷ today's market cap ($1.3B). Same caveat as the cash buyback yield.: 4.03%2016-09 0.9%2026-06 5.1%+444.6% over the window

Vs own 10Y history

P/E: 56th
P/OI: 29th
P/S: 10th
P/B: 25th
P/FCF: 49th

Bar = where today’s multiple sits in USPH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+3.71%

+1.85%

+5.52%

+16.93%

YTD

+11.44%

-2.90%

-18.97%

Financial statements

Open full USPH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

USPH — U.S. Physical Therapy Inc. price, chart and key statistics